Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
Loading...
Date
Authors
Poddighe, Dimitri
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
AbstractThe findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity and may arise in immunologically predisposed children after recurrent/persistent exposure to mycoplasma pneumonia. Copyright 2019, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
Description
Citation
Poddighe, D. (2020). Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy. Journal of Microbiology, Immunology and Infection, 53(1), 188-189.
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States